Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
20.14 USD | +0.78% | -3.04% | -46.31% |
Nov. 27 | Walgreens Boots Alliance, Inc. first light at the end of the tunnel? | ![]() |
Nov. 24 | Stocks edge lower in quiet Thanksgiving trade | AN |
Financials (USD)
Sales 2024 * | 143 B | Sales 2025 * | 149 B | Capitalization | 17.26 B |
---|---|---|---|---|---|
Net income 2024 * | 1,910 M | Net income 2025 * | 2,421 M | EV / Sales 2024 * | 0,17x |
Net Debt 2024 * | 6,924 M | Net Debt 2025 * | 6,253 M | EV / Sales 2025 * | 0,16x |
P/E ratio 2024 * | 10,6x | P/E ratio 2025 * | 7,37x | Employees | 268,500 |
Yield 2024 * | 9,78% | Yield 2025 * | 9,90% | Free-Float | 60.86% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
1 day | +0.55% | ||
1 week | -3.31% | ||
Current month | -5.10% | ||
1 month | -5.19% | ||
3 months | -21.67% | ||
6 months | -33.16% | ||
Current year | -46.45% |
1 week
19.75
20.98

1 month
19.75
22.22

Current year
19.75
37.96

1 year
19.75
42.29

3 years
19.75
57.05

5 years
19.75
86.31

10 years
19.75
97.30

Managers | Title | Age | Since |
---|---|---|---|
Stefano Pessina
CHM | Chairman | 82 | 2012 |
Manmohan Mahajan
DFI | Director of Finance/CFO | 44 | 2016 |
Kevin Ban
CTO | Chief Tech/Sci/R&D Officer | 56 | 2019 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bryan Hanson
BRD | Director/Board Member | 56 | 2022 |
Valerie Jarrett
BRD | Director/Board Member | 66 | 2020 |
Ginger Graham
BRD | Director/Board Member | 67 | 2010 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
5.21% | 235 M€ | -1.67% | ||
2.98% | 24 M€ | -4.57% | - | |
2.61% | 224 M€ | +6.49% |
Date | Price | Change | Volume |
---|---|---|---|
23-11-29 | 20.07 | +0.47% | 5 298 332 |
23-11-28 | 19.98 | -0.65% | 12,559,366 |
23-11-27 | 20.11 | -3.55% | 12,146,213 |
23-11-24 | 20.85 | +0.77% | 4,317,299 |
23-11-22 | 20.69 | -1.38% | 7,682,276 |
Delayed Quote Nasdaq, November 29, 2023 at 11:17 am EST
More quotes
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows:
- retail distribution (90.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.1% of net sales) and International (9.9%). At the end of August 2022, the activity is ensured through 13,343 outlets (including 8,889 in the United States, Puerto Rico and the US Virgin Islands), and through the Internet;
- wholesale distribution (8.4%).
The remaining sales (1.4%) are from the healthcare
Net sales break down geographically as follows: the United States (83.5%), Germany (8.4%), the United Kingdom (6.7%) and other (1.4%).
Sector
Drug Retailers
Calendar
2024-01-03
- Q1 2024 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy

Mean consensus
HOLD
Number of Analysts
16
Last Close Price
19.98USD
Average target price
27.15USD
Spread / Average Target
+35.91%
EPS Revisions
1st Jan change | Capi. (M$) | |
---|---|---|
-46.45% | 17 261 M $ | |
-48.07% | 16 318 M $ | |
+16.36% | 7 429 M $ | |
-17.89% | 5 361 M $ | |
-19.38% | 4 658 M $ | |
-22.42% | 4 128 M $ | |
+9.28% | 3 804 M $ | |
-15.02% | 3 671 M $ | |
+39.51% | 2 712 M $ | |
+190.86% | 2 562 M $ |